View |
|
DR-XY40869
|
Montelukast ( As Sodium)
|
AUROHEX
|
4mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Flamingo Pharmaceuticals Limited
|
India
|
Renewal
|
19 April 2022
|
24 July 2027
|
View |
|
DR-XY40870
|
Cabazitaxel
|
Jevtana
|
60 mg/1.5 mL
|
Concentrate for Solution for Injection (I. V.)
|
Antineoplastic (Taxane)
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
Initial (from Monitored release)
|
31 May 2022
|
13 January 2027
|
View |
|
DR-XY40875
|
Cefuroxime (As Axetil)
|
Kefsyn
|
250 mg/5 mL
|
Granules For Oral Suspension
|
Antibacterial (Second Generation Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
03 March 2022
|
17 May 2027
|
View |
|
DR-XY40877
|
Granisetron
|
Frezitron
|
1mg/ml
|
Concentrate for Solution for IV Infusion
|
Anti-emetics and Anti-nauseants (Serotonin-5HT Antagonists)
|
Labesfal - Laboratorios Almiro S.A.
|
Portugal
|
Renewal
|
10 May 2022
|
15 May 2027
|
View |
|
DR-XY40881
|
Alfacalcidol
|
Philvita Alfa D
|
500 mg
|
Softgel Capsule
|
Bone Metabolism Regulators
|
Phil Inter Pharma Co., Ltd
|
Vietnam
|
Renewal
|
24 June 2022
|
16 May 2027
|
View |
|
DR-XY40882
|
Tramadol (As Hydrochloride)
|
Gesitram
|
50 mg/mL
|
Solution For Injection
|
Opioid Analgesic
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
Automatic Renewal
|
09 March 2022
|
16 May 2027
|
View |
|
DR-XY40887
|
Benzydamine Hydrochloride
|
Difflam Mint
|
3mg
|
Lozenge
|
Stomatological Preparation (Other agents for local oral treatment)
|
Unique Pharmaceuticals Laboratories
|
India
|
Renewal
|
20 May 2022
|
22 May 2027
|
View |
|
DR-XY40888
|
Diphenhydramine Hydrochloride
|
Diphex
|
50mg/mL
|
Solution For injection (Im/Iv)
|
H1 Receptor Antagonist (Antihistamine)
|
Kwality Pharmaceuticals Pvt. Ltd.
|
India
|
Renewal
|
21 April 2022
|
17 May 2027
|
View |
|
DR-XY40893
|
Midazolam
|
Mizam
|
1mg/mL
|
Solution For Injection
|
Psycholeptics (Benzodiazepine derivatives)
|
Global Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
10 March 2022
|
02 August 2027
|
View |
|
DR-XY40899
|
Oxacillin (as Sodium)
|
Peoxa
|
500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co. Ltd.
|
China
|
Initial (Variation)
|
07 September 2023
|
07 September 2028
|
View |
|
DR-XY40900
|
Multivitamins + Minerals
|
Neovite
|
6mg/5.17mg/4000MCG/25mg/40mg
|
Softgel Capsule
|
Multivitamins/Minerals
|
Capsulation and Pharmaceuticals (P) Ltd.
|
India
|
Automatic Renewal
|
06 April 2022
|
17 May 2027
|
View |
|
DR-XY40901
|
Calcitriol + Calcium Citrate + Magnesium Oxide + Zinc Oxide
|
Dcal
|
0.25MCG/425mg/40mg/20mg
|
Capsule
|
Vitamin and Minerals
|
Capsulation and Pharmaceuticals (P) Ltd.
|
India
|
Automatic Renewal
|
05 April 2022
|
17 May 2027
|
View |
|
DR-XY40902
|
Multivitamins + Minerals
|
Revite
|
5000IU/25IU/1.5mg/12MCG/150mg/2mg/1mg/200MCG
|
Softgel Capsule
|
Multivitamins + Minerals
|
Capsulation and Pharmaceuticals (P) Ltd.
|
India
|
Automatic Renewal
|
08 April 2022
|
17 May 2027
|
View |
|
DR-XY40903
|
Ascorbic Acid (as Calcium Ascorbate)
|
Nutri-C
|
413 mg
|
Capsule
|
Vitamin
|
Northfield Laboratories., Inc.
|
Philippines
|
Renewal
|
29 April 2022
|
16 May 2027
|
View |
|
DR-XY40904
|
Cefuruxime (as axetil)
|
Kefezy-125
|
125 mg
|
Tablet
|
Antibacterials ( Cephalosporins )
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
29 March 2022
|
18 May 2027
|
View |
|
DR-XY40905
|
Sildenafil (As Citrate)
|
Greatafil
|
50 mg
|
Film-Coated Tablet
|
Phosphodiesterase Type-5 Inhibitor
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal (Compliance)
|
09 February 2022
|
18 May 2027
|
View |
|
DR-XY40907
|
Losartan potassium + Amlodipine (as camsilate)
|
Cozaar XQ
|
50 mg/5 mg
|
Film-Coated Tablet
|
-
|
Hanmi Pharmaceutical Co., Ltd.
|
Korea
|
Monitored Release
|
21 December 2021
|
17 May 2025
|
View |
|
DR-XY40913
|
Ascorbic Acid + Zinc Ascorbate
|
Procee Plus
|
97.50 mg/9.0 mg per 5 mL
|
Syrup
|
Vitamins
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
07 January 2022
|
17 January 2027
|
View |
|
DR-XY40920
|
Benzydamine Hydrochloride + Cetylpyridinium
|
Difflam Orange
|
3mg/1.33mg
|
Lozenge
|
Non- Steroidal Anti-Inflammatory Drug / Antiseptic
|
Unique Pharmaceuticals Laboratories (Division of J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
Renewal
|
20 June 2022
|
20 June 2027
|
View |
|
DR-XY40921
|
Benzydamine Hydrochloride + Cetylpyridinium Chloride
|
Difflam Eucalyptus & Menthol
|
3mg/1.33mg
|
Lozenge
|
Non-Steroidal Anti-Inflammatory Drug / Antiseptic
|
Unique Pharmaceuticals Lab.
|
India
|
Renewal
|
15 June 2022
|
20 June 2027
|